Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Neoplasms of the CNS

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 363 articles:
HTML format

Single Articles

    January 2020
  1. WITULLA B, Goerig N, Putz F, Frey B, et al
    On PTV definition for glioblastoma based on fiber tracking of diffusion tensor imaging data.
    PLoS One. 2020;15:e0227146.
    PubMed     Abstract available

  2. Retraction: MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7.
    PLoS One. 2020;15:e0228340.

  3. ROTKOPF LT, Wiestler B, Preibisch C, Liesche-Starnecker F, et al
    The wavelet power spectrum of perfusion weighted MRI correlates with tumor vascularity in biopsy-proven glioblastoma samples.
    PLoS One. 2020;15:e0228030.
    PubMed     Abstract available

  4. OTTENSMEIER H, Schlegel PG, Eyrich M, Wolff JE, et al
    Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment.
    PLoS One. 2020;15:e0227693.
    PubMed     Abstract available

  5. LI J, Liu S, Qin Y, Zhang Y, et al
    High-order radiomics features based on T2 FLAIR MRI predict multiple glioma immunohistochemical features: A more precise and personalized gliomas management.
    PLoS One. 2020;15:e0227703.
    PubMed     Abstract available

  6. Retraction: MMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells.
    PLoS One. 2020;15:e0228689.

  7. Retraction: Co-Depletion of Cathepsin B and uPAR Induces G0/G1 Arrest in Glioma via FOXO3a Mediated p27Kip1 Upregulation.
    PLoS One. 2020;15:e0228690.

  8. Retraction: uPAR/Cathepsin B Overexpression Reverse Angiogenesis by Rescuing FAK Phosphorylation in uPAR/Cathepsin B Down Regulated Meningioma.
    PLoS One. 2020;15:e0228681.

  9. MOBARK NA, Alharbi M, Alhabeeb L, AlMubarak L, et al
    Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia.
    PLoS One. 2020;15:e0228356.
    PubMed     Abstract available

  10. Retraction: Downregulation of uPAR and Cathepsin B Induces Apoptosis via Regulation of Bcl-2 and Bax and Inhibition of the PI3K/Akt Pathway in Gliomas.
    PLoS One. 2020;15:e0228688.

  11. RYU JY, Min KL, Chang MJ
    Correction: Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: A retrospective, single-center study.
    PLoS One. 2020;15:e0228800.
    PubMed     Abstract available

  12. WERLENIUS K, Fekete B, Blomstrand M, Caren H, et al
    Patterns of care and clinical outcome in assumed glioblastoma without tissue diagnosis: A population-based study of 131 consecutive patients.
    PLoS One. 2020;15:e0228480.
    PubMed     Abstract available

  13. Retraction: Differential SELEX in Human Glioma Cell Lines.
    PLoS One. 2020;15:e0228838.

  14. LEE RH, Kim JM, Cheong JH, Ryu JI, et al
    Significance of skull osteoporosis to the development of peritumoral brain edema after LINAC-based radiation treatment in patients with intracranial meningioma.
    PLoS One. 2020;15:e0226312.
    PubMed     Abstract available

  15. Correction to Retraction of: EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell Growth.
    PLoS One. 2020;15:e0230016.
    PubMed     Abstract available

  16. BELTER A, Barciszewski J, Barciszewska AM
    Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions.
    PLoS One. 2020;15:e0229534.
    PubMed     Abstract available

  17. BEHLING F, Barrantes-Freer A, Behnes CL, Stockhammer F, et al
    Expression of Olig2, Nestin, NogoA and AQP4 have no impact on overall survival in IDH-wildtype glioblastoma.
    PLoS One. 2020;15:e0229274.
    PubMed     Abstract available

  18. MCKELVEY KJ, Hudson AL, Prasanna Kumar R, Wilmott JS, et al
    Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model.
    PLoS One. 2020;15:e0226444.
    PubMed     Abstract available

  19. Expression of Concern: ZEB2 Mediates Multiple Pathways Regulating Cell Proliferation, Migration, Invasion, and Apoptosis in Glioma.
    PLoS One. 2020;15:e0231386.

  20. Retraction: Upregulation of PTEN in Glioma Cells by Cord Blood Mesenchymal Stem Cells Inhibits Migration via Downregulation of the PI3K/Akt Pathway.
    PLoS One. 2020;15:e0231283.

  21. MASSEY SC, White H, Whitmire P, Doyle T, et al
    Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma.
    PLoS One. 2020;15:e0230492.
    PubMed     Abstract available

  22. CHAGAS SARAIVA CW, Cardoso SC, Groppo DP, De Salles AAF, et al
    Gamma Knife radiosurgery for vestibular schwannomas: Evaluation of planning using the sphericity degree of the target volume.
    PLoS One. 2020;15:e0225638.
    PubMed     Abstract available

  23. FUENFGELD B, Machler P, Fischer DR, Esposito G, et al
    Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination.
    PLoS One. 2020;15:e0230618.
    PubMed     Abstract available

  24. HYUN DG, Choi CM, Lee DH, Kim SW, et al
    Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis.
    PLoS One. 2020;15:e0231546.
    PubMed     Abstract available

  25. GIRARD A, Saint-Jalmes H, Chaboub N, Le Reste PJ, et al
    Optimization of time frame binning for FDOPA uptake quantification in glioma.
    PLoS One. 2020;15:e0232141.
    PubMed     Abstract available

  26. FABRE MS, Stanton NM, Slatter TL, Lee S, et al
    The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapy.
    PLoS One. 2020;15:e0231470.
    PubMed     Abstract available

  27. SHIEH LT, Guo HR, Ho CH, Lin LC, et al
    Survival of glioblastoma treated with a moderately escalated radiation dose-Results of a retrospective analysis.
    PLoS One. 2020;15:e0233188.
    PubMed     Abstract available

  28. SUAREZ-GARCIA JG, Hernandez-Lopez JM, Moreno-Barbosa E, de Celis-Alonso B, et al
    A simple model for glioma grading based on texture analysis applied to conventional brain MRI.
    PLoS One. 2020;15:e0228972.
    PubMed     Abstract available

  29. MIRCHI N, Bissonnette V, Yilmaz R, Ledwos N, et al
    The Virtual Operative Assistant: An explainable artificial intelligence tool for simulation-based training in surgery and medicine.
    PLoS One. 2020;15:e0229596.
    PubMed     Abstract available

  30. VAIDYA M, Sugaya K
    Differential sequences and single nucleotide polymorphism of exosomal SOX2 DNA in cancer.
    PLoS One. 2020;15:e0229309.
    PubMed     Abstract available

  31. HUA B, Ding X, Xiong M, Zhang F, et al
    Alterations of functional and structural connectivity in patients with brain metastases.
    PLoS One. 2020;15:e0233833.
    PubMed     Abstract available

  32. LEE JH, Kim HS, Yoon YC, Cha MJ, et al
    Differentiating between spinal schwannomas and meningiomas using MRI: A focus on cystic change.
    PLoS One. 2020;15:e0233623.
    PubMed     Abstract available

  33. AHLSTEDT J, Konradsson E, Ceberg C, Redebrandt HN, et al
    Increased effect of two-fraction radiotherapy in conjunction with IDO1 inhibition in experimental glioblastoma.
    PLoS One. 2020;15:e0233617.
    PubMed     Abstract available

  34. ZHU L, Nazeri A, Pacia CP, Yue Y, et al
    Focused ultrasound for safe and effective release of brain tumor biomarkers into the peripheral circulation.
    PLoS One. 2020;15:e0234182.
    PubMed     Abstract available

  35. Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFkappaB Transactivation through NIK/IKK in Human Glioma Cells.
    PLoS One. 2020;15:e0234365.

  36. TAKASHIMA Y, Kawaguchi A, Iwadate Y, Hondoh H, et al
    miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.
    PLoS One. 2020;15:e0229577.
    PubMed     Abstract available

  37. BHOWMICK R, Sarkar RR
    Differential suitability of reactive oxygen species and the role of glutathione in regulating paradoxical behavior in gliomas: A mathematical perspective.
    PLoS One. 2020;15:e0235204.
    PubMed     Abstract available

  38. KHOSHNEVIS M, Carozzo C, Brown R, Bardies M, et al
    Feasibility of intratumoral 165Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipig.
    PLoS One. 2020;15:e0234772.
    PubMed     Abstract available

  39. CASANA-ESLAVA RV, Ortega-Martorell S, Lisboa PJ, Candiota AP, et al
    Robust Conditional Independence maps of single-voxel Magnetic Resonance Spectra to elucidate associations between brain tumours and metabolites.
    PLoS One. 2020;15:e0235057.
    PubMed     Abstract available

  40. SHARMA KD, Schaal D, Kore RA, Hamzah RN, et al
    Glioma-derived exosomes drive the differentiation of neural stem cells to astrocytes.
    PLoS One. 2020;15:e0234614.
    PubMed     Abstract available

  41. WALLENBORN M, Xu LX, Kirsten H, Rohani L, et al
    Molecular analyses of glioblastoma stem-like cells and glioblastoma tissue.
    PLoS One. 2020;15:e0234986.
    PubMed     Abstract available

  42. GRONSETH E, Gupta A, Koceja C, Kumar S, et al
    Astrocytes influence medulloblastoma phenotypes and CD133 surface expression.
    PLoS One. 2020;15:e0235852.
    PubMed     Abstract available

  43. HOU X, Yang D, Li D, Liu M, et al
    A new simple brain segmentation method for extracerebral intracranial tumors.
    PLoS One. 2020;15:e0230754.
    PubMed     Abstract available

  44. ZHENG C, Berger NA, Li L, Xu R, et al
    Epigenetic age acceleration and clinical outcomes in gliomas.
    PLoS One. 2020;15:e0236045.
    PubMed     Abstract available

  45. OH SA, Yea JW, Park JW, Park J, et al
    Use of a head-tilting baseplate during volumetric-modulated arc therapy (VMAT) to better protect organs at risk in hippocampal sparing whole brain radiotherapy (HS-WBRT).
    PLoS One. 2020;15:e0232430.
    PubMed     Abstract available

  46. ABDELAZEEM RM, Youssef D, El-Azab J, Hassab-Elnaby S, et al
    Three-dimensional visualization of brain tumor progression based accurate segmentation via comparative holographic projection.
    PLoS One. 2020;15:e0236835.
    PubMed     Abstract available

  47. GARRETT MC, O'Shea TM, Wollenberg AL, Bernstein AM, et al
    Injectable diblock copolypeptide hydrogel provides platform to deliver effective concentrations of paclitaxel to an intracranial xenograft model of glioblastoma.
    PLoS One. 2020;15:e0219632.
    PubMed     Abstract available

  48. CHEN VC, Lin KY, Tsai YH, Weng JC, et al
    Connectome analysis of brain functional network alterations in breast cancer survivors with and without chemotherapy.
    PLoS One. 2020;15:e0232548.
    PubMed     Abstract available

  49. GRAHAM LS, Montgomery B, Cheng HH, Yu EY, et al
    Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies.
    PLoS One. 2020;15:e0233260.
    PubMed     Abstract available

  50. PARKER D, Ould Ismail AA, Wolf R, Brem S, et al
    Freewater estimatoR using iNtErpolated iniTialization (FERNET): Characterizing peritumoral edema using clinically feasible diffusion MRI data.
    PLoS One. 2020;15:e0233645.
    PubMed     Abstract available

  51. KOPER-LENKIEWICZ OM, Kaminska J, Reszec J, Dymicka-Piekarska V, et al
    Elevated plasma 20S proteasome chymotrypsin-like activity is correlated with IL-8 levels and associated with an increased risk of death in glial brain tumor patients.
    PLoS One. 2020;15:e0238406.
    PubMed     Abstract available

  52. LIM SJ, Yeo I, Park CW, Lee H, et al
    Risk factors for osteonecrosis of the femoral head in brain tumor patients receiving corticosteroid after surgery.
    PLoS One. 2020;15:e0238368.
    PubMed     Abstract available

  53. MINEA RO, Duc TC, Swenson SD, Cho HY, et al
    Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas.
    PLoS One. 2020;15:e0238238.
    PubMed     Abstract available

  54. WILHELMY F, Hantsche A, Wende T, Kasper J, et al
    Perioperative anticoagulation in patients with intracranial meningioma: No increased risk of intracranial hemorrhage?
    PLoS One. 2020;15:e0238387.
    PubMed     Abstract available

    January 2019
  55. CHEN QF, Huang T, Shen L, Li W, et al
    Predictive value of a nomogram for hepatocellular carcinoma with brain metastasis at initial diagnosis: A population-based study.
    PLoS One. 2019;14:e0209293.
    PubMed     Abstract available

  56. YU X, Dobrikov M, Keir ST, Gromeier M, et al
    Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors.
    PLoS One. 2019;14:e0210608.
    PubMed     Abstract available

  57. SHACKLEFORD GM, Mahdi MY, Moats RA, Hawes D, et al
    Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma.
    PLoS One. 2019;14:e0206394.
    PubMed     Abstract available

  58. LATINI F, Fahlstrom M, Berntsson SG, Larsson EM, et al
    A novel radiological classification system for cerebral gliomas: The Brain-Grid.
    PLoS One. 2019;14:e0211243.
    PubMed     Abstract available

  59. MIRAB F, Kang YJ, Majd S
    Preparation and characterization of size-controlled glioma spheroids using agarose hydrogel microwells.
    PLoS One. 2019;14:e0211078.
    PubMed     Abstract available

  60. ROBSON JP, Remke M, Kool M, Julian E, et al
    Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells.
    PLoS One. 2019;14:e0210665.
    PubMed     Abstract available

  61. VOLNITSKIY A, Shtam T, Burdakov V, Kovalev R, et al
    Abnormal activity of transcription factors gli in high-grade gliomas.
    PLoS One. 2019;14:e0211980.
    PubMed     Abstract available

  62. BENAVIDES-SERRATO A, Lee J, Holmes B, Landon KA, et al
    Correction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
    PLoS One. 2019;14:e0212160.
    PubMed     Abstract available

  63. LANGE F, Wesslau K, Porath K, Hornschemeyer J, et al
    AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.
    PLoS One. 2019;14:e0211644.
    PubMed     Abstract available

  64. CAREY MR, Callaghan BC, Kerber KA, Skolarus LE, et al
    Impact of early headache neuroimaging on time to malignant brain tumor diagnosis: A retrospective cohort study.
    PLoS One. 2019;14:e0211599.
    PubMed     Abstract available

  65. HOHMANN T, Feese K, Ghadban C, Dehghani F, et al
    On the influence of cannabinoids on cell morphology and motility of glioblastoma cells.
    PLoS One. 2019;14:e0212037.
    PubMed     Abstract available

  66. VECERA M, Sana J, Oppelt J, Tichy B, et al
    Testing of library preparation methods for transcriptome sequencing of real life glioblastoma and brain tissue specimens: A comparative study with special focus on long non-coding RNAs.
    PLoS One. 2019;14:e0211978.
    PubMed     Abstract available

  67. ARRIAGADA C, Luchsinger C, Gonzalez AE, Schwenke T, et al
    The knocking down of the oncoprotein Golgi phosphoprotein 3 in T98G cells of glioblastoma multiforme disrupts cell migration by affecting focal adhesion dynamics in a focal adhesion kinase-dependent manner.
    PLoS One. 2019;14:e0212321.
    PubMed     Abstract available

  68. VENTERO MP, Fuentes-Baile M, Quereda C, Perez-Valeciano E, et al
    Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.
    PLoS One. 2019;14:e0212581.
    PubMed     Abstract available

  69. RAKOTONJANAHARY J, Gravier N, Lambron J, De Carli E, et al
    Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy-Analysis of a French pediatric historical cohort.
    PLoS One. 2019;14:e0212107.
    PubMed     Abstract available

  70. ZIMMERMANN M, Rossler K, Kaltenhauser M, Grummich P, et al
    Comparative fMRI and MEG localization of cortical sensorimotor function: Bimodal mapping supports motor area reorganization in glioma patients.
    PLoS One. 2019;14:e0213371.
    PubMed     Abstract available

  71. TANAKA Y, Nakazawa T, Nakamura M, Nishimura F, et al
    Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro.
    PLoS One. 2019;14:e0212455.
    PubMed     Abstract available

  72. Correction: A novel technique of serial biopsy in mouse brain tumour models.
    PLoS One. 2019;14:e0214401.
    PubMed     Abstract available

  73. GRABOWSKA M, Grzeskowiak BF, Szutkowski K, Wawrzyniak D, et al
    Nano-mediated delivery of double-stranded RNA for gene therapy of glioblastoma multiforme.
    PLoS One. 2019;14:e0213852.
    PubMed     Abstract available

  74. WHITE ML, Zhang Y, Yu F, Shonka N, et al
    Post-operative perfusion and diffusion MR imaging and tumor progression in high-grade gliomas.
    PLoS One. 2019;14:e0213905.
    PubMed     Abstract available

  75. JENSEN-KONDERING U, Helle M, Lindner T, Jansen O, et al
    Non-invasive qualitative and semiquantitative presurgical investigation of the feeding vasculature to intracranial meningiomas using superselective arterial spin labeling.
    PLoS One. 2019;14:e0215145.
    PubMed     Abstract available

  76. RYU JA, Jung W, Jung YJ, Kwon DY, et al
    Early prediction of neurological outcome after barbiturate coma therapy in patients undergoing brain tumor surgery.
    PLoS One. 2019;14:e0215280.
    PubMed     Abstract available

  77. VENTERO MP, Fuentes-Baile M, Quereda C, Perez-Valeciano E, et al
    Correction: Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.
    PLoS One. 2019;14:e0215714.
    PubMed     Abstract available

  78. SAINI J, Gupta RK, Kumar M, Singh A, et al
    Comparative evaluation of cerebral gliomas using rCBV measurements during sequential acquisition of T1-perfusion and T2*-perfusion MRI.
    PLoS One. 2019;14:e0215400.
    PubMed     Abstract available

  79. JUNG E, de Los Reyes V AA, Pumares KJA, Kim Y, et al
    Strategies in regulating glioblastoma signaling pathways and anti-invasion therapy.
    PLoS One. 2019;14:e0215547.
    PubMed     Abstract available

  80. YUN PJ, Wang GC, Chen YY, Wu TH, et al
    Brain metastases in resected non-small cell lung cancer: The impact of different tyrosine kinase inhibitors.
    PLoS One. 2019;14:e0215923.
    PubMed     Abstract available

  81. TAKASHIMA Y, Kawaguchi A, Hayano A, Yamanaka R, et al
    CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme.
    PLoS One. 2019;14:e0216825.
    PubMed     Abstract available

  82. INADA M, Shindo M, Kobayashi K, Sato A, et al
    Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells.
    PLoS One. 2019;14:e0216358.
    PubMed     Abstract available

  83. SCHULTEN HJ, Hussein D
    Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas.
    PLoS One. 2019;14:e0215452.
    PubMed     Abstract available

  84. JABLONSKA PA, Diez-Valle R, Perez-Larraya JG, Moreno-Jimenez M, et al
    Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.
    PLoS One. 2019;14:e0217881.
    PubMed     Abstract available

  85. CHOI Y, Ahn KJ, Nam Y, Jang J, et al
    Analysis of peritumoral hyperintensity on pre-operative T2-weighted MR images in glioblastoma: Additive prognostic value of Minkowski functionals.
    PLoS One. 2019;14:e0217785.
    PubMed     Abstract available

  86. NAM MW, Kim JM, Cheong JH, Ryu JI, et al
    Paradoxical relationship between body mass index and bone mineral density in patients with non-small cell lung cancer with brain metastasis.
    PLoS One. 2019;14:e0218825.
    PubMed     Abstract available

  87. CARDONA AF, Ruiz-Patino A, Zatarain-Barron ZL, Hakim F, et al
    Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib.
    PLoS One. 2019;14:e0217340.
    PubMed     Abstract available

  88. OPPERMANN H, Faust H, Yamanishi U, Meixensberger J, et al
    Carnosine inhibits glioblastoma growth independent from PI3K/Akt/mTOR signaling.
    PLoS One. 2019;14:e0218972.
    PubMed     Abstract available

  89. MEANEY C, Stastna M, Kardar M, Kohandel M, et al
    Spatial optimization for radiation therapy of brain tumours.
    PLoS One. 2019;14:e0217354.
    PubMed     Abstract available

  90. JABLONSKA PA, Diez-Valle R, Gallego Perez-Larraya J, Moreno-Jimenez M, et al
    Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.
    PLoS One. 2019;14:e0219614.
    PubMed     Abstract available

  91. FLEISCHMANN DF, Unterrainer M, Corradini S, Rottler M, et al
    Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.
    PLoS One. 2019;14:e0216111.
    PubMed     Abstract available

  92. ZHANG L, Peterson TE, Lu VM, Parney IF, et al
    Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells.
    PLoS One. 2019;14:e0220569.
    PubMed     Abstract available

  93. ORTEGA-MARTORELL S, Candiota AP, Thomson R, Riley P, et al
    Embedding MRI information into MRSI data source extraction improves brain tumour delineation in animal models.
    PLoS One. 2019;14:e0220809.
    PubMed     Abstract available

  94. LAMMER F, Delbridge C, Wurstle S, Neff F, et al
    Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.
    PLoS One. 2019;14:e0221502.
    PubMed     Abstract available

  95. RAVI V, Madhankumar AB, Abraham T, Slagle-Webb B, et al
    Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms.
    PLoS One. 2019;14:e0221952.
    PubMed     Abstract available

  96. Retraction: EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell Growth.
    PLoS One. 2019;14:e0222210.

  97. SHIVRAM H, Le SV, Iyer VR
    PRC2 activates interferon-stimulated genes indirectly by repressing miRNAs in glioblastoma.
    PLoS One. 2019;14:e0222435.
    PubMed     Abstract available

  98. CHAHAL KK, Li J, Kufareva I, Parle M, et al
    Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma.
    PLoS One. 2019;14:e0214901.
    PubMed     Abstract available

  99. FALTERMEIER C, Chai T, Syed S, Lau N, et al
    Survival of infants </=24 months of age with brain tumors: A population-based study using the SEER database.
    PLoS One. 2019;14:e0223051.
    PubMed     Abstract available

  100. LIU Y, Song C, Shen F, Zhang J, et al
    IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcgammaRIIB phosphorylation in glioblastoma.
    PLoS One. 2019;14:e0222999.
    PubMed     Abstract available

  101. EIJGELAAR R, De Witt Hamer PC, Peeters CFW, Barkhof F, et al
    Voxelwise statistical methods to localize practice variation in brain tumor surgery.
    PLoS One. 2019;14:e0222939.
    PubMed     Abstract available

  102. MITSUYA K, Nakasu Y, Hayashi N, Deguchi S, et al
    Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study.
    PLoS One. 2019;14:e0210074.
    PubMed     Abstract available

  103. ZHENG L, Zhang Y, Hao S, Chen L, et al
    A proteomic clock for malignant gliomas: The role of the environment in tumorigenesis at the presymptomatic stage.
    PLoS One. 2019;14:e0223558.
    PubMed     Abstract available

  104. Retraction: The Different Role of Notch1 and Notch2 in Astrocytic Gliomas.
    PLoS One. 2019;14:e0224117.

  105. KHAN AU, Mahjabeen I, Malik MA, Hussain MZ, et al
    Modulation of brain tumor risk by genetic SNPs in PARP1gene: Hospital based case control study.
    PLoS One. 2019;14:e0223882.
    PubMed     Abstract available

  106. SATO J, Shimomura A, Kawauchi J, Matsuzaki J, et al
    Brain metastasis-related microRNAs in patients with advanced breast cancer.
    PLoS One. 2019;14:e0221538.
    PubMed     Abstract available

  107. BERENDSEN S, van Bodegraven E, Seute T, Spliet WGM, et al
    Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates.
    PLoS One. 2019;14:e0222717.
    PubMed     Abstract available

  108. FALTERMEIER C, Chai T, Syed S, Lau N, et al
    Correction: Survival of infants </=24 months of age with brain tumors: A population-based study using the SEER database.
    PLoS One. 2019;14:e0224570.
    PubMed     Abstract available

  109. DE MEULENAERE V, Bonte E, Verhoeven J, Kalala Okito JP, et al
    Adjuvant therapeutic potential of tonabersat in the standard treatment of glioblastoma: A preclinical F98 glioblastoma rat model study.
    PLoS One. 2019;14:e0224130.
    PubMed     Abstract available

  110. TAKASHIMA Y, Kawaguchi A, Iwadate Y, Hondoh H, et al
    MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
    PLoS One. 2019;14:e0210400.
    PubMed     Abstract available

  111. PAQUETTE K, Coltin H, Boivin A, Amre D, et al
    Cancer risk in children and young adults born preterm: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0210366.
    PubMed     Abstract available

  112. WANG Q, Perez-Carrillo GJG, Ponisio MR, LaMontagne P, et al
    Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation.
    PLoS One. 2019;14:e0225093.
    PubMed     Abstract available

  113. D'SOUZA S, Ormond DR, Costabile J, Thompson JA, et al
    Fiber-tract localized diffusion coefficients highlight patterns of white matter disruption induced by proximity to glioma.
    PLoS One. 2019;14:e0225323.
    PubMed     Abstract available

  114. CHEN KC, Chen PH, Ho KH, Shih CM, et al
    IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/beta-catenin pathway.
    PLoS One. 2019;14:e0225913.
    PubMed     Abstract available

  115. RYU JY, Min KL, Chang MJ
    Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: A retrospective, single-center study.
    PLoS One. 2019;14:e0225599.
    PubMed     Abstract available

  116. SCOTT SE, Penfold C, Saji S, Curtis S, et al
    'It was nothing that you would think was anything': Qualitative analysis of appraisal and help seeking preceding brain cancer diagnosis.
    PLoS One. 2019;14:e0213599.
    PubMed     Abstract available

  117. SCHULT T, Hauser TK, Klose U, Hurth H, et al
    Fiber visualization for preoperative glioma assessment: Tractography versus local connectivity mapping.
    PLoS One. 2019;14:e0226153.
    PubMed     Abstract available

  118. DATTA K, Lauritzen MH, Merchant M, Jang T, et al
    Reversed metabolic reprogramming as a measure of cancer treatment efficacy in rat C6 glioma model.
    PLoS One. 2019;14:e0225313.
    PubMed     Abstract available

  119. MAITI P, Plemmons A, Dunbar GL
    Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
    PLoS One. 2019;14:e0225660.
    PubMed     Abstract available

  120. BERENS ME, Sood A, Barnholtz-Sloan JS, Graf JF, et al
    Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas.
    PLoS One. 2019;14:e0219724.
    PubMed     Abstract available

  121. ZHAO Z, Wu W, Duan X, Zeng G, et al
    The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases.
    PLoS One. 2019;14:e0215861.
    PubMed     Abstract available

  122. LEE CC, Soon YY, Tan CL, Koh WY, et al
    Discordance of epidermal growth factor receptor mutation between primary lung tumor and paired distant metastases in non-small cell lung cancer: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0218414.
    PubMed     Abstract available

  123. YAMASHITA S, Takeshima H, Matsumoto F, Yamasaki K, et al
    Detection of the KIAA1549-BRAF fusion gene in cells forming microvascular proliferations in pilocytic astrocytoma.
    PLoS One. 2019;14:e0220146.
    PubMed     Abstract available

  124. GOREN L, Zhang G, Kaushik S, Breslin PAS, et al
    (-)-Oleocanthal and (-)-oleocanthal-rich olive oils induce lysosomal membrane permeabilization in cancer cells.
    PLoS One. 2019;14:e0216024.
    PubMed     Abstract available

  125. ZHANG K, Yun SD, Triphan SMF, Sturm VJ, et al
    Vessel architecture imaging using multiband gradient-echo/spin-echo EPI.
    PLoS One. 2019;14:e0220939.
    PubMed     Abstract available

  126. STOJADINOVIC S, Yan Y, Leiker A, Ahn C, et al
    Considerations of target surface area and the risk of radiosurgical toxicity.
    PLoS One. 2019;14:e0224047.
    PubMed     Abstract available

  127. DE REZENDE ACP, Weltman E, Chen MJ, Helito JK, et al
    Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation.
    PLoS One. 2019;14:e0226350.
    PubMed     Abstract available

  128. PODLESEK D, Zolal A, Kirsch M, Schackert G, et al
    Olfactory bulb volume changes associated with trans-sphenoidal pituitary surgery.
    PLoS One. 2019;14:e0224594.
    PubMed     Abstract available

  129. PASTERNAK-PIETRZAK K, Moszczynska E, Roszkowski M, Kot K, et al
    Long-term outcome in patients after treatment for Cushing's disease in childhood.
    PLoS One. 2019;14:e0226033.
    PubMed     Abstract available

    January 2018
  130. SUN G, SiMa G, Wu C, Fan Y, et al
    Decreased MiR-17 in glioma cells increased cell viability and migration by increasing the expression of Cyclin D1, p-Akt and Akt.
    PLoS One. 2018;13:e0190515.
    PubMed     Abstract available

  131. NESKA-MATUSZEWSKA M, Bladowska J, Sasiadek M, Zimny A, et al
    Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
    PLoS One. 2018;13:e0191341.
    PubMed     Abstract available

  132. JONES DC, Scanteianu A, DiStefano M, Bouhaddou M, et al
    Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma.
    PLoS One. 2018;13:e0190664.
    PubMed     Abstract available

  133. BAGHIROV H, Snipstad S, Sulheim E, Berg S, et al
    Ultrasound-mediated delivery and distribution of polymeric nanoparticles in the normal brain parenchyma of a metastatic brain tumour model.
    PLoS One. 2018;13:e0191102.
    PubMed     Abstract available

  134. WILLIAM D, Walther M, Schneider B, Linnebacher M, et al
    Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.
    PLoS One. 2018;13:e0191511.
    PubMed     Abstract available

  135. GARCIA-VILLAESCUSA A, Morales-Tatay JM, Monleon-Salvado D, Gonzalez-Darder JM, et al
    Using NMR in saliva to identify possible biomarkers of glioblastoma and chronic periodontitis.
    PLoS One. 2018;13:e0188710.
    PubMed     Abstract available

  136. CHANG WY, Wu YL, Su PL, Yang SC, et al
    The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.
    PLoS One. 2018;13:e0192161.
    PubMed     Abstract available

  137. LIM WH, Choi SH, Yoo RE, Kang KM, et al
    Does radiation therapy increase gadolinium accumulation in the brain?: Quantitative analysis of T1 shortening using R1 relaxometry in glioblastoma multiforme patients.
    PLoS One. 2018;13:e0192838.
    PubMed     Abstract available

  138. MA C, Nguyen HPT, Luwor RB, Stylli SS, et al
    A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
    PLoS One. 2018;13:e0189452.
    PubMed     Abstract available

  139. MIYAUCHI E, Furuta T, Ohtsuki S, Tachikawa M, et al
    Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics.
    PLoS One. 2018;13:e0193799.
    PubMed     Abstract available

  140. YU KK, Taylor JT, Pathmanaban ON, Youshani AS, et al
    High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma.
    PLoS One. 2018;13:e0193694.
    PubMed     Abstract available

  141. PRESUTTI D, Ceccarelli M, Micheli L, Papoff G, et al
    Tis21-gene therapy inhibits medulloblastoma growth in a murine allograft model.
    PLoS One. 2018;13:e0194206.
    PubMed     Abstract available

  142. HERRERA-PEREZ RM, Voytik-Harbin SL, Sarkaria JN, Pollok KE, et al
    Presence of stromal cells in a bioengineered tumor microenvironment alters glioblastoma migration and response to STAT3 inhibition.
    PLoS One. 2018;13:e0194183.
    PubMed     Abstract available

  143. ZADOR Z, King AT, Geifman N
    New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
    PLoS One. 2018;13:e0194701.
    PubMed     Abstract available

  144. DEIKE-HOFMANN K, Thunemann D, Breckwoldt MO, Schwarz D, et al
    Sensitivity of different MRI sequences in the early detection of melanoma brain metastases.
    PLoS One. 2018;13:e0193946.
    PubMed     Abstract available

  145. MOREAU J, Khalil T, Dupic G, Chautard E, et al
    Second course of stereotactic radiosurgery for locally recurrent brain metastases: Safety and efficacy.
    PLoS One. 2018;13:e0195608.
    PubMed     Abstract available

  146. BERLOW NE, Svalina MN, Quist MJ, Settelmeyer TP, et al
    IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma.
    PLoS One. 2018;13:e0193565.
    PubMed     Abstract available

  147. GE Y, Zhong Y, Ji G, Lu Q, et al
    Preparation and characterization of Fe3O4@Au-C225 composite targeted nanoparticles for MRI of human glioma.
    PLoS One. 2018;13:e0195703.
    PubMed     Abstract available

  148. BLANC-DURAND P, Van Der Gucht A, Schaefer N, Itti E, et al
    Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study.
    PLoS One. 2018;13:e0195798.
    PubMed     Abstract available

  149. AL-SERORI H, Ferk F, Kundi M, Bileck A, et al
    Mobile phone specific electromagnetic fields induce transient DNA damage and nucleotide excision repair in serum-deprived human glioblastoma cells.
    PLoS One. 2018;13:e0193677.
    PubMed     Abstract available

  150. CAPPELLETTI P, Tallarita E, Rabattoni V, Campomenosi P, et al
    Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line.
    PLoS One. 2018;13:e0196283.
    PubMed     Abstract available

  151. LOW SYY, Wei CM, Chang KTE, Huak CY, et al
    Intra-operative cerebrospinal fluid sampling versus post-operative lumbar puncture for detection of leptomeningeal disease in malignant paediatric brain tumours.
    PLoS One. 2018;13:e0196696.
    PubMed     Abstract available

  152. PAN Y, Duron C, Bush EC, Ma Y, et al
    Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.
    PLoS One. 2018;13:e0190001.
    PubMed     Abstract available

  153. MICHAUD K, de Tayrac M, D'Astous M, Paquet C, et al
    Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas.
    PLoS One. 2018;13:e0193213.
    PubMed     Abstract available

  154. HOLSKEN A, Schwarz M, Gillmann C, Pfister C, et al
    Characterization of the murine orthotopic adamantinomatous craniopharyngioma PDX model by MRI in correlation with histology.
    PLoS One. 2018;13:e0197895.
    PubMed     Abstract available

  155. BALERMPAS P, Stera S, Muller von der Grun J, Loutfi-Krauss B, et al
    Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    PLoS One. 2018;13:e0198692.
    PubMed     Abstract available

  156. LIAO WC, Liao CK, Tsai YH, Tseng TJ, et al
    DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
    PLoS One. 2018;13:e0198364.
    PubMed     Abstract available

  157. NGUEMGO KOUAM P, Rezniczek GA, Kochanneck A, Priesch-Grzeszkowiak B, et al
    Robo1 and vimentin regulate radiation-induced motility of human glioblastoma cells.
    PLoS One. 2018;13:e0198508.
    PubMed     Abstract available

  158. RATAI EM, Zhang Z, Fink J, Muzi M, et al
    ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
    PLoS One. 2018;13:e0198548.
    PubMed     Abstract available

  159. BOHN A, Braley A, Rodriguez de la Vega P, Zevallos JC, et al
    The association between race and survival in glioblastoma patients in the US: A retrospective cohort study.
    PLoS One. 2018;13:e0198581.
    PubMed     Abstract available

  160. CHIHARA D, Fanale MA, Miranda RN, Noorani M, et al
    The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.
    PLoS One. 2018;13:e0191461.
    PubMed     Abstract available

  161. BLANC-DURAND P, Van Der Gucht A, Verger A, Langen KJ, et al
    Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas.
    PLoS One. 2018;13:e0199379.
    PubMed     Abstract available

  162. NOWACKA A, Smuczynski W, Rosc D, Wozniak-Dabrowska K, et al
    Serum VEGF-A concentrations in patients with central nervous system (CNS) tumors.
    PLoS One. 2018;13:e0192395.
    PubMed     Abstract available

  163. FABELO H, Ortega S, Ravi D, Kiran BR, et al
    Spatio-spectral classification of hyperspectral images for brain cancer detection during surgical operations.
    PLoS One. 2018;13:e0193721.
    PubMed     Abstract available

  164. MCNEILL RS, Stroobant EE, Smithberger E, Canoutas DA, et al
    PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition.
    PLoS One. 2018;13:e0200014.
    PubMed     Abstract available

  165. SAHIN A, Sanchez C, Bullain S, Waterman P, et al
    Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.
    PLoS One. 2018;13:e0199414.
    PubMed     Abstract available

  166. CONTI S, Vexler A, Edry-Botzer L, Kalich-Philosoph L, et al
    Combined acetyl-11-keto-beta-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
    PLoS One. 2018;13:e0198627.
    PubMed     Abstract available

  167. OKOLIE O, Irvin DM, Bago JR, Sheets K, et al
    Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection.
    PLoS One. 2018;13:e0198596.
    PubMed     Abstract available

  168. HUANG HW, Yan LM, Yang YL, He X, et al
    Bi-frontal pneumocephalus is an independent risk factor for early postoperative agitation in adult patients admitted to intensive care unit after elective craniotomy for brain tumor: A prospective cohort study.
    PLoS One. 2018;13:e0201064.
    PubMed     Abstract available

  169. YOON JS, So CH, Lee HS, Lim JS, et al
    The prevalence of brain abnormalities in boys with central precocious puberty may be overestimated.
    PLoS One. 2018;13:e0195209.
    PubMed     Abstract available

  170. SOUZA TKF, Nucci MP, Mamani JB, da Silva HR, et al
    Image and motor behavior for monitoring tumor growth in C6 glioma model.
    PLoS One. 2018;13:e0201453.
    PubMed     Abstract available

  171. PROTTI A, Jones KL, Bonal DM, Qin L, et al
    Development and validation of a new MRI simulation technique that can reliably estimate optimal in vivo scanning parameters in a glioblastoma murine model.
    PLoS One. 2018;13:e0200611.
    PubMed     Abstract available

  172. PETRELLI F, Lazzari C, Ardito R, Borgonovo K, et al
    Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies.
    PLoS One. 2018;13:e0201425.
    PubMed     Abstract available

  173. GONG S, Zhang F, Norton I, Essayed WI, et al
    Free water modeling of peritumoral edema using multi-fiber tractography: Application to tracking the arcuate fasciculus for neurosurgical planning.
    PLoS One. 2018;13:e0197056.
    PubMed     Abstract available

  174. LIU B, Arakawa Y, Yokogawa R, Tokunaga S, et al
    PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+ and CD8+ infiltrating lymphocytes.
    PLoS One. 2018;13:e0194594.
    PubMed     Abstract available

  175. HAO J, Godley A, Shoemake JD, Han Z, et al
    The effects of extra high dose rate irradiation on glioma stem-like cells.
    PLoS One. 2018;13:e0202533.
    PubMed     Abstract available

  176. ZHAO Z, Yang G, Lin Y, Pang H, et al
    Automated glioma detection and segmentation using graphical models.
    PLoS One. 2018;13:e0200745.
    PubMed     Abstract available

  177. YUAN AL, Ricks CB, Bohm AK, Lun X, et al
    ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts.
    PLoS One. 2018;13:e0202860.
    PubMed     Abstract available

  178. REESE MJ, Knapp DW, Anderson KM, Mund JA, et al
    In vitro effect of chlorambucil on human glioma cell lines (SF767 and U87-MG), and human microvascular endothelial cell (HMVEC) and endothelial progenitor cells (ECFCs), in the context of plasma chlorambucil concentrations in tumor-bearing dogs.
    PLoS One. 2018;13:e0203517.
    PubMed     Abstract available

  179. PARK GHJ, Yang SH, Baek HM
    900MHz 1H-/13C-NMR analysis of 2-hydroxyglutarate and other brain metabolites in human brain tumor tissue extracts.
    PLoS One. 2018;13:e0203379.
    PubMed     Abstract available

  180. GENNATAS ED, Wu A, Braunstein SE, Morin O, et al
    Preoperative and postoperative prediction of long-term meningioma outcomes.
    PLoS One. 2018;13:e0204161.
    PubMed     Abstract available

  181. GARCIA CR, Slone SA, Pittman T, St Clair WH, et al
    Comprehensive evaluation of treatment and outcomes of low-grade diffuse gliomas.
    PLoS One. 2018;13:e0203639.
    PubMed     Abstract available

  182. BROSNAN-CASHMAN JA, Yuan M, Graham MK, Rizzo AJ, et al
    ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner.
    PLoS One. 2018;13:e0204159.
    PubMed     Abstract available

  183. Correction: Glioma IL13Ralpha2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis.
    PLoS One. 2018;13:e0204463.
    PubMed     Abstract available

  184. TIETZE A, Nielsen A, Klaerke Mikkelsen I, Bo Hansen M, et al
    Bayesian modeling of Dynamic Contrast Enhanced MRI data in cerebral glioma patients improves the diagnostic quality of hemodynamic parameter maps.
    PLoS One. 2018;13:e0202906.
    PubMed     Abstract available

  185. ZHANG Z, Wu L, Wang J, Li G, et al
    Correction: Opposing Effects of PI3K/Akt and Smad-Dependent Signaling Pathways in NAG-1-Induced Glioblastoma Cell Apoptosis.
    PLoS One. 2018;13:e0205391.
    PubMed     Abstract available

  186. KIM Y, Kang H, Powathil G, Kim H, et al
    Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma.
    PLoS One. 2018;13:e0204865.
    PubMed     Abstract available

  187. KRESSNER M, Arlt F, Riepl W, Meixensberger J, et al
    Prognostic factors of microsurgical treatment of intracranial meningiomas - A multivariate analysis.
    PLoS One. 2018;13:e0202520.
    PubMed     Abstract available

  188. ARNLI MB, Winther TL, Lydersen S, Torp SH, et al
    Prognostic value of ErbB2/HER2 in human meningiomas.
    PLoS One. 2018;13:e0205846.
    PubMed     Abstract available

  189. FUKUNAGA T, Fujita Y, Kishima H, Yamashita T, et al
    Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma.
    PLoS One. 2018;13:e0206552.
    PubMed     Abstract available

  190. NAMGOONG S, Cheong HS, Kim JH, Kim LH, et al
    Association analysis of RTEL1 variants with risk of adult gliomas in a Korean population.
    PLoS One. 2018;13:e0207660.
    PubMed     Abstract available

  191. LIN MC, Li CZ, Hsieh CC, Hong KT, et al
    Preoperative grading of intracranial meningioma by magnetic resonance spectroscopy (1H-MRS).
    PLoS One. 2018;13:e0207612.
    PubMed     Abstract available

  192. LEITNER J, Pelster S, Schopf V, Berghoff AS, et al
    High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases.
    PLoS One. 2018;13:e0207849.
    PubMed     Abstract available

  193. VAIDYA M, Bacchus M, Sugaya K
    Differential sequences of exosomal NANOG DNA as a potential diagnostic cancer marker.
    PLoS One. 2018;13:e0197782.
    PubMed     Abstract available

  194. SELIGER C, Schaertl J, Gerken M, Luber C, et al
    Use of statins or NSAIDs and survival of patients with high-grade glioma.
    PLoS One. 2018;13:e0207858.
    PubMed     Abstract available

  195. LEUTHARDT EC, Guzman G, Bandt SK, Hacker C, et al
    Integration of resting state functional MRI into clinical practice - A large single institution experience.
    PLoS One. 2018;13:e0198349.
    PubMed     Abstract available

  196. ALLAWAY R, Angus SP, Beauchamp RL, Blakeley JO, et al
    Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.
    PLoS One. 2018;13:e0197350.
    PubMed     Abstract available

  197. WILLIAMS SK, Weiner ZP, Gilmore RD
    Human neuroglial cells internalize Borrelia burgdorferi by coiling phagocytosis mediated by Daam1.
    PLoS One. 2018;13:e0197413.
    PubMed     Abstract available

  198. JUSSILA MP, Remes T, Anttonen J, Harila-Saari A, et al
    Late vertebral side effects in long-term survivors of irradiated childhood brain tumor.
    PLoS One. 2018;13:e0209193.
    PubMed     Abstract available

  199. HINO T, Togao O, Hiwatashi A, Yamashita K, et al
    Clinical efficacy of simplified intravoxel incoherent motion imaging using three b-values for differentiating high- and low-grade gliomas.
    PLoS One. 2018;13:e0209796.
    PubMed     Abstract available

  200. KUNDU S, Cheng Y, Shin M, Manyam G, et al
    Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
    PLoS One. 2018;13:e0195070.
    PubMed     Abstract available

  201. GARCIA-MARTINEZ A, Sottile J, Fajardo C, Riesgo P, et al
    Is it time to consider the expression of specific-pituitary hormone genes when typifying pituitary tumours?
    PLoS One. 2018;13:e0198877.
    PubMed     Abstract available

  202. MORETTI IF, Franco DG, de Almeida Galatro TF, Oba-Shinjo SM, et al
    Plasmatic membrane toll-like receptor expressions in human astrocytomas.
    PLoS One. 2018;13:e0199211.
    PubMed     Abstract available

  203. KORSHOEJ AR, Hansen FL, Mikic N, von Oettingen G, et al
    Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations.
    PLoS One. 2018;13:e0201957.
    PubMed     Abstract available

  204. CHEN J
    The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis.
    PLoS One. 2018;13:e0200909.
    PubMed     Abstract available

  205. YOON RG, Kim HS, Hong GS, Park JE, et al
    Joint approach of diffusion- and perfusion-weighted MRI in intra-axial mass like lesions in clinical practice simulation.
    PLoS One. 2018;13:e0202891.
    PubMed     Abstract available

  206. LUHTALA N, Hunter T
    Failure to detect functional transfer of active K-Ras protein from extracellular vesicles into recipient cells in culture.
    PLoS One. 2018;13:e0203290.
    PubMed     Abstract available

  207. BERTERO L, Anfossi V, Osella-Abate S, Disanto MG, et al
    Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series.
    PLoS One. 2018;13:e0203570.
    PubMed     Abstract available

  208. DENNISON KL, Chack AC, Hickman MP, Harenda QE, et al
    Ept7, a quantitative trait locus that controls estrogen-induced pituitary lactotroph hyperplasia in rat, is orthologous to a locus in humans that has been associated with numerous cancer types and common diseases.
    PLoS One. 2018;13:e0204727.
    PubMed     Abstract available

  209. RICHTIG G, Hoeller C, Wolf M, Wolf I, et al
    Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study.
    PLoS One. 2018;13:e0204729.
    PubMed     Abstract available

  210. NEUMANN JO, Campos B, Younes B, Jakobs M, et al
    Frame-based stereotactic biopsies using an intraoperative MR-scanner are as safe and effective as conventional stereotactic procedures.
    PLoS One. 2018;13:e0205772.
    PubMed     Abstract available

  211. PERDOMO-PANTOJA A, Mejia-Perez SI, Reynoso-Noveron N, Gomez-Flores-Ramos L, et al
    Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma.
    PLoS One. 2018;13:e0206590.
    PubMed     Abstract available

  212. DE MEULENAERE V, Neyt S, Vandeghinste B, Mollet P, et al
    Species-dependent extracranial manifestations of a brain seeking breast cancer cell line.
    PLoS One. 2018;13:e0208340.
    PubMed     Abstract available

    January 2017
  213. HENNIKA T, Hu G, Olaciregui NG, Barton KL, et al
    Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models.
    PLoS One. 2017;12:e0169485.
    PubMed     Abstract available

  214. JONES JE, Esler WP, Patel R, Lanba A, et al
    Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells.
    PLoS One. 2017;12:e0169566.
    PubMed     Abstract available

  215. CILIBRASI C, Riva G, Romano G, Cadamuro M, et al
    Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway.
    PLoS One. 2017;12:e0169854.
    PubMed     Abstract available

  216. QIN H, Janowski M, Pearl MS, Malysz-Cymborska I, et al
    Rabbit Model of Human Gliomas: Implications for Intra-Arterial Drug Delivery.
    PLoS One. 2017;12:e0169656.
    PubMed     Abstract available

  217. EIDEL O, Burth S, Neumann JO, Kieslich PJ, et al
    Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology.
    PLoS One. 2017;12:e0169292.
    PubMed     Abstract available

  218. ESTEVE-CODINA A, Arpi O, Martinez-Garcia M, Pineda E, et al
    A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples.
    PLoS One. 2017;12:e0170632.
    PubMed     Abstract available

  219. DOMENIS R, Cesselli D, Toffoletto B, Bourkoula E, et al
    Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells.
    PLoS One. 2017;12:e0169932.
    PubMed     Abstract available

  220. LIU PC, Lu G, Deng Y, Wang CD, et al
    Inhibition of NF-kappaB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy.
    PLoS One. 2017;12:e0171157.
    PubMed     Abstract available

  221. LEE W, Lim S, Kim Y
    The role of myosin II in glioma invasion: A mathematical model.
    PLoS One. 2017;12:e0171312.
    PubMed     Abstract available

  222. HSIEH KL, Tsai RJ, Teng YC, Lo CM, et al
    Effect of a computer-aided diagnosis system on radiologists' performance in grading gliomas with MRI.
    PLoS One. 2017;12:e0171342.
    PubMed     Abstract available

  223. CHLAPEK P, Zitterbart K, Kren L, Filipova L, et al
    Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups.
    PLoS One. 2017;12:e0172552.
    PubMed     Abstract available

  224. HUBER T, Alber G, Bette S, Kaesmacher J, et al
    Progressive disease in glioblastoma: Benefits and limitations of semi-automated volumetry.
    PLoS One. 2017;12:e0173112.
    PubMed     Abstract available

  225. BROWN DV, Filiz G, Daniel PM, Hollande F, et al
    Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
    PLoS One. 2017;12:e0172791.
    PubMed     Abstract available

  226. POLLAK J, Rai KG, Funk CC, Arora S, et al
    Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.
    PLoS One. 2017;12:e0172884.
    PubMed     Abstract available

  227. WINTHER TL, Torp SH
    DNA topoisomerase IIalpha and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery.
    PLoS One. 2017;12:e0172316.
    PubMed     Abstract available

  228. XU W, Wang Q, Shao A, Xu B, et al
    The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0173430.
    PubMed     Abstract available

  229. JIA P, Li F, Gu W, Zhang W, et al
    Gab3 overexpression in human glioma mediates Akt activation and tumor cell proliferation.
    PLoS One. 2017;12:e0173473.
    PubMed     Abstract available

  230. KAYA B, Goceri E, Becker A, Elder B, et al
    Automated fluorescent miscroscopic image analysis of PTBP1 expression in glioma.
    PLoS One. 2017;12:e0170991.
    PubMed     Abstract available

  231. LEE CC, Chen PH, Ho KH, Shih CM, et al
    The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA.
    PLoS One. 2017;12:e0173890.
    PubMed     Abstract available

  232. CONNOLLY NP, Stokum JA, Schneider CS, Ozawa T, et al
    Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer.
    PLoS One. 2017;12:e0174557.
    PubMed     Abstract available

  233. SHERRY-LYNES MM, Sengupta S, Kulkarni S, Cochran BH, et al
    Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3.
    PLoS One. 2017;12:e0174775.
    PubMed     Abstract available

  234. HSU SY, Ou CY, Ho YN, Huang YH, et al
    Application of Surgical Apgar Score in intracranial meningioma surgery.
    PLoS One. 2017;12:e0174328.
    PubMed     Abstract available

  235. REIMER C, Deike K, Graf M, Reimer P, et al
    Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps.
    PLoS One. 2017;12:e0174620.
    PubMed     Abstract available

  236. ROGERS S, Hii H, Huang J, Ancliffe M, et al
    A novel technique of serial biopsy in mouse brain tumour models.
    PLoS One. 2017;12:e0175169.
    PubMed     Abstract available

  237. YANG L, Mu Y, Cui H, Liang Y, et al
    MiR-9-3p augments apoptosis induced by H2O2 through down regulation of Herpud1 in glioma.
    PLoS One. 2017;12:e0174839.
    PubMed     Abstract available

  238. SUN L, Moritake T, Ito K, Matsumoto Y, et al
    Metabolic analysis of radioresistant medulloblastoma stem-like clones and potential therapeutic targets.
    PLoS One. 2017;12:e0176162.
    PubMed     Abstract available

  239. MERCURIO L, Cecchetti S, Ricci A, Pacella A, et al
    Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells.
    PLoS One. 2017;12:e0176108.
    PubMed     Abstract available

  240. SANCHEZ-DIAZ PC, Chang JC, Moses ES, Dao T, et al
    Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is associated with stem-like cancer cell functions in pediatric high-grade glioma.
    PLoS One. 2017;12:e0176879.
    PubMed     Abstract available

  241. YANG M, Guo W, Yang C, Tang J, et al
    Mobile phone use and glioma risk: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0175136.
    PubMed     Abstract available

  242. HILL VK, Kim JS, James CD, Waldman T, et al
    Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing.
    PLoS One. 2017;12:e0176683.
    PubMed     Abstract available

  243. ERMINI L, Morganti E, Post A, Yeganeh B, et al
    Imaging mass spectrometry identifies prognostic ganglioside species in rodent intracranial transplants of glioma and medulloblastoma.
    PLoS One. 2017;12:e0176254.
    PubMed     Abstract available

  244. BENAVIDES-SERRATO A, Lee J, Holmes B, Landon KA, et al
    Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
    PLoS One. 2017;12:e0176599.
    PubMed     Abstract available

  245. RAUSCHERT I, Aldunate F, Preussner J, Arocena-Sutz M, et al
    Promoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells.
    PLoS One. 2017;12:e0175953.
    PubMed     Abstract available

  246. HOWE JR 6TH, Li ES, Streeter SE, Rahme GJ, et al
    MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation.
    PLoS One. 2017;12:e0177661.
    PubMed     Abstract available

  247. PETUSHKOVA NA, Zgoda VG, Pyatnitskiy MA, Larina OV, et al
    Post-translational modifications of FDA-approved plasma biomarkers in glioblastoma samples.
    PLoS One. 2017;12:e0177427.
    PubMed     Abstract available

  248. SCHNEIDER T, Kuhne JF, Bittrich P, Schroeder J, et al
    Edema is not a reliable diagnostic sign to exclude small brain metastases.
    PLoS One. 2017;12:e0177217.
    PubMed     Abstract available

  249. BOOTH TC, Larkin TJ, Yuan Y, Kettunen MI, et al
    Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.
    PLoS One. 2017;12:e0176528.
    PubMed     Abstract available

  250. BLYSTAD I, Warntjes JBM, Smedby O, Lundberg P, et al
    Quantitative MRI for analysis of peritumoral edema in malignant gliomas.
    PLoS One. 2017;12:e0177135.
    PubMed     Abstract available

  251. MCDONALD JT, Gao X, Steber C, Lee Breed J, et al
    Host mediated inflammatory influence on glioblastoma multiforme recurrence following high-dose ionizing radiation.
    PLoS One. 2017;12:e0178155.
    PubMed     Abstract available

  252. KILLICK-COLE CL, Singleton WGB, Bienemann AS, Asby DJ, et al
    Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma.
    PLoS One. 2017;12:e0176855.
    PubMed     Abstract available

  253. WEI KC, Chen CY, Feng LY, Huang WT, et al
    The rs16906252:C>T SNP is not associated with increased overall survival or temozolomide response in a Han-Chinese glioma cohort.
    PLoS One. 2017;12:e0178842.
    PubMed     Abstract available

  254. HENARES-MOLINA A, Benzekry S, Lara PC, Garcia-Rojo M, et al
    Non-standard radiotherapy fractionations delay the time to malignant transformation of low-grade gliomas.
    PLoS One. 2017;12:e0178552.
    PubMed     Abstract available

  255. KUTWIN M, Sawosz E, Jaworski S, Wierzbicki M, et al
    Assessment of the proliferation status of glioblastoma cell and tumour tissue after nanoplatinum treatment.
    PLoS One. 2017;12:e0178277.
    PubMed     Abstract available

  256. MEI Y, Bi WL, Greenwald NF, Agar NY, et al
    Genomic profile of human meningioma cell lines.
    PLoS One. 2017;12:e0178322.
    PubMed     Abstract available

  257. SCHWARTZBAUM J, Wang M, Root E, Pietrzak M, et al
    A nested case-control study of 277 prediagnostic serum cytokines and glioma.
    PLoS One. 2017;12:e0178705.
    PubMed     Abstract available

  258. SUNWOO L, Kim YJ, Choi SH, Kim KG, et al
    Computer-aided detection of brain metastasis on 3D MR imaging: Observer performance study.
    PLoS One. 2017;12:e0178265.
    PubMed     Abstract available

  259. YANG CF, Ho HL, Lin SC, Hsu CY, et al
    Detection of human cytomegalovirus in glioblastoma among Taiwanese subjects.
    PLoS One. 2017;12:e0179366.
    PubMed     Abstract available

  260. MOLINA D, Perez-Beteta J, Martinez-Gonzalez A, Martino J, et al
    Lack of robustness of textural measures obtained from 3D brain tumor MRIs impose a need for standardization.
    PLoS One. 2017;12:e0178843.
    PubMed     Abstract available

  261. STEWART DC, Rubiano A, Dyson K, Simmons CS, et al
    Mechanical characterization of human brain tumors from patients and comparison to potential surgical phantoms.
    PLoS One. 2017;12:e0177561.
    PubMed     Abstract available

  262. WARD NP, Poff AM, Koutnik AP, D'Agostino DP, et al
    Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells.
    PLoS One. 2017;12:e0180061.
    PubMed     Abstract available

  263. KUMAR R, de Mooij T, Peterson TE, Kaptzan T, et al
    Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane.
    PLoS One. 2017;12:e0179012.
    PubMed     Abstract available

  264. ZHAO P, Hall J, Durston M, Voydanoff A, et al
    BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma.
    PLoS One. 2017;12:e0179948.
    PubMed     Abstract available

  265. LEE JC, Chuang KS, Chen YW, Hsu FY, et al
    Preliminary dosimetric study on feasibility of multi-beam boron neutron capture therapy in patients with diffuse intrinsic pontine glioma without craniotomy.
    PLoS One. 2017;12:e0180461.
    PubMed     Abstract available

  266. FOSMARK S, Hellwege S, Dahlrot RH, Jensen KL, et al
    APNG as a prognostic marker in patients with glioblastoma.
    PLoS One. 2017;12:e0178693.
    PubMed     Abstract available

  267. KESSEL KA, Hesse J, Straube C, Zimmer C, et al
    Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma.
    PLoS One. 2017;12:e0180457.
    PubMed     Abstract available

  268. SELIGER C, Meier CR, Becker C, Jick SS, et al
    Diabetes, use of metformin, and the risk of meningioma.
    PLoS One. 2017;12:e0181089.
    PubMed     Abstract available

  269. AL-SAFFAR NMS, Agliano A, Marshall LV, Jackson LE, et al
    In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells.
    PLoS One. 2017;12:e0180263.
    PubMed     Abstract available

  270. MASCHIO M, Beghi E, Casazza MML, Colicchio G, et al
    Patterns of care of brain tumor-related epilepsy. A cohort study done in Italian Epilepsy Center.
    PLoS One. 2017;12:e0180470.
    PubMed     Abstract available

  271. ZEH R, Sheikh S, Xia L, Pierce J, et al
    The second window ICG technique demonstrates a broad plateau period for near infrared fluorescence tumor contrast in glioblastoma.
    PLoS One. 2017;12:e0182034.
    PubMed     Abstract available

  272. PARK JE, Ryu KH, Kim HS, Kim HW, et al
    Perfusion of surgical cavity wall enhancement in early post-treatment MR imaging may stratify the time-to-progression in glioblastoma.
    PLoS One. 2017;12:e0181933.
    PubMed     Abstract available

  273. CHEN J, Mao S, Li H, Zheng M, et al
    The pathological structure of the perivascular niche in different microvascular patterns of glioblastoma.
    PLoS One. 2017;12:e0182183.
    PubMed     Abstract available

  274. BOGDANSKA MU, Bodnar M, Piotrowska MJ, Murek M, et al
    A mathematical model describes the malignant transformation of low grade gliomas: Prognostic implications.
    PLoS One. 2017;12:e0179999.
    PubMed     Abstract available

  275. FISHER CJ, Niu C, Foltz W, Chen Y, et al
    ALA-PpIX mediated photodynamic therapy of malignant gliomas augmented by hypothermia.
    PLoS One. 2017;12:e0181654.
    PubMed     Abstract available

    Graph-theoretical model of global human interactome reveals enhanced long-range communicability in cancer networks.
    PLoS One. 2017;12:e0170953.
    PubMed     Abstract available

  277. MALCHENKO S, Sredni ST, Bi Y, Margaryan NV, et al
    Stabilization of HIF-1alpha and HIF-2alpha, up-regulation of MYCC and accumulation of stabilized p53 constitute hallmarks of CNS-PNET animal model.
    PLoS One. 2017;12:e0173106.
    PubMed     Abstract available

  278. CHIBA R, Akiya M, Hashimura M, Oguri Y, et al
    ALK signaling cascade confers multiple advantages to glioblastoma cells through neovascularization and cell proliferation.
    PLoS One. 2017;12:e0183516.
    PubMed     Abstract available

  279. ROSAGER AM, Sorensen MD, Dahlrot RH, Hansen S, et al
    Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
    PLoS One. 2017;12:e0182954.
    PubMed     Abstract available

  280. GAO L, Chen B, Li J, Yang F, et al
    Wnt/beta-catenin signaling pathway inhibits the proliferation and apoptosis of U87 glioma cells via different mechanisms.
    PLoS One. 2017;12:e0181346.
    PubMed     Abstract available

  281. GAO B, Shen X, Shiroishi MS, Pang M, et al
    A pilot study of pre-operative motor dysfunction from gliomas in the region of corticospinal tract: Evaluation with diffusion tensor imaging.
    PLoS One. 2017;12:e0182795.
    PubMed     Abstract available

  282. RAMIS R, Tamayo-Uria I, Gomez-Barroso D, Lopez-Abente G, et al
    Risk factors for central nervous system tumors in children: New findings from a case-control study.
    PLoS One. 2017;12:e0171881.
    PubMed     Abstract available

  283. MARIGIL M, Martinez-Velez N, Dominguez PD, Idoate MA, et al
    Development of a DIPG Orthotopic Model in Mice Using an Implantable Guide-Screw System.
    PLoS One. 2017;12:e0170501.
    PubMed     Abstract available

  284. SCRIBNER E, Fathallah-Shaykh HM
    Single Cell Mathematical Model Successfully Replicates Key Features of GBM: Go-Or-Grow Is Not Necessary.
    PLoS One. 2017;12:e0169434.
    PubMed     Abstract available

  285. SAUWEN N, Acou M, Bharath HN, Sima DM, et al
    The successive projection algorithm as an initialization method for brain tumor segmentation using non-negative matrix factorization.
    PLoS One. 2017;12:e0180268.
    PubMed     Abstract available

  286. KIVINIEMI V, Korhonen V, Kortelainen J, Rytky S, et al
    Real-time monitoring of human blood-brain barrier disruption.
    PLoS One. 2017;12:e0174072.
    PubMed     Abstract available

  287. GOODS BA, Hernandez AL, Lowther DE, Lucca LE, et al
    Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme.
    PLoS One. 2017;12:e0181538.
    PubMed     Abstract available

  288. FORNVIK K, Maddahi A, Persson O, Osther K, et al
    C1-inactivator is upregulated in glioblastoma.
    PLoS One. 2017;12:e0183086.
    PubMed     Abstract available

  289. CHENG B, Morales LD, Zhang Y, Mito S, et al
    Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line.
    PLoS One. 2017;12:e0184324.
    PubMed     Abstract available

  290. FELDMAN LA, Fabre MS, Grasso C, Reid D, et al
    Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas.
    PLoS One. 2017;12:e0184250.
    PubMed     Abstract available

  291. WERNECK DE CARVALHO LE, Sarraf JS, Semblano AA, Moreira MA, et al
    Central nervous system tumours profile at a referral center in the Brazilian Amazon region, 1997-2014.
    PLoS One. 2017;12:e0174439.
    PubMed     Abstract available

  292. RAMACHANDRAN RK, Sorensen MD, Aaberg-Jessen C, Hermansen SK, et al
    Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.
    PLoS One. 2017;12:e0172234.
    PubMed     Abstract available

  293. SCHAEFER S, Svenstrup TH, Guerra B
    The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells.
    PLoS One. 2017;12:e0177706.
    PubMed     Abstract available

  294. WILLIAM D, Mokri P, Lamp N, Linnebacher M, et al
    Amplification of the EGFR gene can be maintained and modulated by variation of EGF concentrations in in vitro models of glioblastoma multiforme.
    PLoS One. 2017;12:e0185208.
    PubMed     Abstract available

  295. WANG ZQ, Zhang MY, Deng ML, Weng NQ, et al
    Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    PLoS One. 2017;12:e0184969.
    PubMed     Abstract available

  296. SUN M, Zhang Z, Ma C, Chen S, et al
    Quantitative analysis of retinal layers on three-dimensional spectral-domain optical coherence tomography for pituitary adenoma.
    PLoS One. 2017;12:e0179532.
    PubMed     Abstract available

  297. BECHER OJ, Millard NE, Modak S, Kushner BH, et al
    A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
    PLoS One. 2017;12:e0178593.
    PubMed     Abstract available

  298. WINTHER TL, Torp SH
    The anti-apoptotic protein survivin can improve the prognostication of meningioma patients.
    PLoS One. 2017;12:e0185217.
    PubMed     Abstract available

  299. EUSKIRCHEN P, Radke J, Schmidt MS, Schulze Heuling E, et al
    Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma.
    PLoS One. 2017;12:e0185376.
    PubMed     Abstract available

  300. KWIATKOWSKI SC, Guerrero PA, Hirota S, Chen Z, et al
    Neuropilin-1 modulates TGFbeta signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy.
    PLoS One. 2017;12:e0185065.
    PubMed     Abstract available

  301. DADONE-MONTAUDIE B, Ambrosetti D, Dufour M, Darcourt J, et al
    [18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression.
    PLoS One. 2017;12:e0184625.
    PubMed     Abstract available

  302. ISAEVSKA E, Manasievska M, Alessi D, Mosso ML, et al
    Cancer incidence rates and trends among children and adolescents in Piedmont, 1967-2011.
    PLoS One. 2017;12:e0181805.
    PubMed     Abstract available

  303. REICHERT JL, Chocholous M, Leiss U, Pletschko T, et al
    Neuronal correlates of cognitive function in patients with childhood cerebellar tumor lesions.
    PLoS One. 2017;12:e0180200.
    PubMed     Abstract available

  304. SANCHEZ-TEJADA L, Sanchez-Ortiga R, Lamas C, Camara R, et al
    Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas.
    PLoS One. 2017;12:e0180039.
    PubMed     Abstract available

  305. KORSHOEJ AR, Hansen FL, Thielscher A, von Oettingen GB, et al
    Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study.
    PLoS One. 2017;12:e0179214.
    PubMed     Abstract available

  306. LIU Y, Stojadinovic S, Hrycushko B, Wardak Z, et al
    A deep convolutional neural network-based automatic delineation strategy for multiple brain metastases stereotactic radiosurgery.
    PLoS One. 2017;12:e0185844.
    PubMed     Abstract available

  307. HARDELL L, Carlberg M
    Mobile phones, cordless phones and rates of brain tumors in different age groups in the Swedish National Inpatient Register and the Swedish Cancer Register during 1998-2015.
    PLoS One. 2017;12:e0185461.
    PubMed     Abstract available

  308. GARCIA-RECIO M, Cladera A, Bento L, Dominguez J, et al
    Analysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experience.
    PLoS One. 2017;12:e0179595.
    PubMed     Abstract available

  309. OH SA, Park JW, Yea JW, Kim SK, et al
    Evaluations of the setup discrepancy between BrainLAB 6D ExacTrac and cone-beam computed tomography used with the imaging guidance system Novalis-Tx for intracranial stereotactic radiosurgery.
    PLoS One. 2017;12:e0177798.
    PubMed     Abstract available

  310. MELEIS AM, Mahtabfar A, Danish S, Foty RA, et al
    Dexamethasone-mediated inhibition of Glioblastoma neurosphere dispersal in an ex vivo organotypic neural assay.
    PLoS One. 2017;12:e0186483.
    PubMed     Abstract available

  311. HSU CY, Ho HL, Lin SC, Ho TD, et al
    The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.
    PLoS One. 2017;12:e0186430.
    PubMed     Abstract available

  312. KIM SW, Shin HJ, Hwang JH, Shin JS, et al
    Image similarity evaluation of the bulk-density-assigned synthetic CT derived from MRI of intracranial regions for radiation treatment.
    PLoS One. 2017;12:e0185082.
    PubMed     Abstract available

  313. LEE JY, Park JE, Kim HS, Kim SO, et al
    Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients.
    PLoS One. 2017;12:e0183916.
    PubMed     Abstract available

  314. PRABHU VV, Lulla AR, Madhukar NS, Ralff MD, et al
    Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
    PLoS One. 2017;12:e0180541.
    PubMed     Abstract available

  315. MITRA S, Banerjee S, Hayashi Y
    Volumetric brain tumour detection from MRI using visual saliency.
    PLoS One. 2017;12:e0187209.
    PubMed     Abstract available

  316. GRENIER JK, Foureman PA, Sloma EA, Miller AD, et al
    RNA-seq transcriptome analysis of formalin fixed, paraffin-embedded canine meningioma.
    PLoS One. 2017;12:e0187150.
    PubMed     Abstract available

  317. MADHU B, Jauhiainen A, McGuire S, Griffiths JR, et al
    Exploration of human brain tumour metabolism using pairwise metabolite-metabolite correlation analysis (MMCA) of HR-MAS 1H NMR spectra.
    PLoS One. 2017;12:e0185980.
    PubMed     Abstract available

  318. FAN W, Fan SS, Feng J, Xiao D, et al
    Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma.
    PLoS One. 2017;12:e0185563.
    PubMed     Abstract available

  319. COROLLER TP, Bi WL, Huynh E, Abedalthagafi M, et al
    Radiographic prediction of meningioma grade by semantic and radiomic features.
    PLoS One. 2017;12:e0187908.
    PubMed     Abstract available

  320. HERMANSEN SK, Sorensen MD, Hansen A, Knudsen S, et al
    A 4-miRNA signature to predict survival in glioblastomas.
    PLoS One. 2017;12:e0188090.
    PubMed     Abstract available

  321. OH J, Kim Y, Che L, Kim JB, et al
    Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma.
    PLoS One. 2017;12:e0178881.
    PubMed     Abstract available

  322. KYEONG S, Cha YJ, Ahn SG, Suh SH, et al
    Subtypes of breast cancer show different spatial distributions of brain metastases.
    PLoS One. 2017;12:e0188542.
    PubMed     Abstract available

  323. LIU H, Liu N, Cheng Y, Jin W, et al
    Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathway.
    PLoS One. 2017;12:e0189353.
    PubMed     Abstract available

  324. JENSEN KV, Cseh O, Aman A, Weiss S, et al
    The JAK2/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft model.
    PLoS One. 2017;12:e0189670.
    PubMed     Abstract available

  325. ZETTERLING M, Berhane L, Alafuzoff I, Jakola AS, et al
    Prognostic markers for survival in patients with oligodendroglial tumors; a single-institution review of 214 cases.
    PLoS One. 2017;12:e0188419.
    PubMed     Abstract available

  326. LEE JY, Park JE, Shim WH, Jung SC, et al
    Joint approach based on clinical and imaging features to distinguish non-neoplastic from neoplastic pituitary stalk lesions.
    PLoS One. 2017;12:e0187989.
    PubMed     Abstract available

    January 2016
  327. KO CC, Tai MH, Li CF, Chen TY, et al
    Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.
    PLoS One. 2016;11:e0162565.
    PubMed     Abstract available

  328. JARMUSCH AK, Alfaro CM, Pirro V, Hattab EM, et al
    Differential Lipid Profiles of Normal Human Brain Matter and Gliomas by Positive and Negative Mode Desorption Electrospray Ionization - Mass Spectrometry Imaging.
    PLoS One. 2016;11:e0163180.
    PubMed     Abstract available

  329. MIN W, Dai D, Wang J, Zhang D, et al
    Long Noncoding RNA miR210HG as a Potential Biomarker for the Diagnosis of Glioma.
    PLoS One. 2016;11:e0160451.
    PubMed     Abstract available

  330. KINOSHITA M, Sakai M, Arita H, Shofuda T, et al
    Introduction of High Throughput Magnetic Resonance T2-Weighted Image Texture Analysis for WHO Grade 2 and 3 Gliomas.
    PLoS One. 2016;11:e0164268.
    PubMed     Abstract available

  331. YE H, Huang H, Cao F, Chen M, et al
    HSPB1 Enhances SIRT2-Mediated G6PD Activation and Promotes Glioma Cell Proliferation.
    PLoS One. 2016;11:e0164285.
    PubMed     Abstract available

  332. HICKS MJ, Chiuchiolo MJ, Ballon D, Dyke JP, et al
    Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma.
    PLoS One. 2016;11:e0162978.
    PubMed     Abstract available

  333. KORSHOEJ AR, Saturnino GB, Rasmussen LK, von Oettingen G, et al
    Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study.
    PLoS One. 2016;11:e0164051.
    PubMed     Abstract available

  334. BOLCAEN J, Lybaert K, Moerman L, Descamps B, et al
    Correction: Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.
    PLoS One. 2016;11:e0164208.
    PubMed     Abstract available

  335. SAGARA A, Igarashi K, Otsuka M, Karasawa T, et al
    Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR.
    PLoS One. 2016;11:e0164250.
    PubMed     Abstract available

  336. YE R, Shen T, Jiang Y, Xu L, et al
    The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis.
    PLoS One. 2016;11:e0164388.
    PubMed     Abstract available

  337. FREITAG MT, Maier-Hein KH, Binczyk F, Laun FB, et al
    Early Detection of Malignant Transformation in Resected WHO II Low-Grade Glioma Using Diffusion Tensor-Derived Quantitative Measures.
    PLoS One. 2016;11:e0164679.
    PubMed     Abstract available

  338. LEMAIRE L, Nel J, Franconi F, Bastiat G, et al
    Perfluorocarbon-Loaded Lipid Nanocapsules to Assess the Dependence of U87-Human Glioblastoma Tumor pO2 on In Vitro Expansion Conditions.
    PLoS One. 2016;11:e0165479.
    PubMed     Abstract available

  339. SUFIT A, Lee-Sherick AB, DeRyckere D, Rupji M, et al
    MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme.
    PLoS One. 2016;11:e0165107.
    PubMed     Abstract available

  340. FYLLINGEN EH, Stensjoen AL, Berntsen EM, Solheim O, et al
    Glioblastoma Segmentation: Comparison of Three Different Software Packages.
    PLoS One. 2016;11:e0164891.
    PubMed     Abstract available

  341. DAHLIN AM, Wibom C, Ghasimi S, Brannstrom T, et al
    Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor.
    PLoS One. 2016;11:e0163067.
    PubMed     Abstract available

  342. LUM MA, Martin AJ, Alexander MD, McCoy DB, et al
    Intra-Arterial MR Perfusion Imaging of Meningiomas: Comparison to Digital Subtraction Angiography and Intravenous MR Perfusion Imaging.
    PLoS One. 2016;11:e0163554.
    PubMed     Abstract available

  343. JANISZEWSKA J, Posadas I, Jativa P, Bugaj-Zarebska M, et al
    Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or Astrocytes.
    PLoS One. 2016;11:e0165704.
    PubMed     Abstract available

  344. KIRSCHNER S, Murle B, Felix M, Arns A, et al
    Imaging of Orthotopic Glioblastoma Xenografts in Mice Using a Clinical CT Scanner: Comparison with Micro-CT and Histology.
    PLoS One. 2016;11:e0165994.
    PubMed     Abstract available

  345. MARTINEZ NJ, Rai G, Yasgar A, Lea WA, et al
    Correction: A High-Throughput Screen Identifies 2,9-Diazaspiro[5.5]Undecanes as Inducers of the Endoplasmic Reticulum Stress Response with Cytotoxic Activity in 3D Glioma Cell Models.
    PLoS One. 2016;11:e0166506.
    PubMed     Abstract available

  346. CRISMAN TJ, Zelaya I, Laks DR, Zhao Y, et al
    Identification of an Efficient Gene Expression Panel for Glioblastoma Classification.
    PLoS One. 2016;11:e0164649.
    PubMed     Abstract available

  347. KIM BR, Choi SH, Yun TJ, Lee ST, et al
    MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction.
    PLoS One. 2016;11:e0166096.
    PubMed     Abstract available

  348. SUNWOO L, Yun TJ, You SH, Yoo RE, et al
    Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR Imaging.
    PLoS One. 2016;11:e0166662.
    PubMed     Abstract available

  349. DEUSCHL C, Goericke S, Grueneisen J, Sawicki LM, et al
    Simultaneous 11C-Methionine Positron Emission Tomography/Magnetic Resonance Imaging of Suspected Primary Brain Tumors.
    PLoS One. 2016;11:e0167596.
    PubMed     Abstract available

  350. CHENG Y, Zhao G, Zhang S, Nigim F, et al
    AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
    PLoS One. 2016;11:e0167094.
    PubMed     Abstract available

  351. WESTON C, Klobusicky J, Weston J, Connor J, et al
    Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas.
    PLoS One. 2016;11:e0166593.
    PubMed     Abstract available

  352. CHEN PH, Cheng CH, Shih CM, Ho KH, et al
    The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
    PLoS One. 2016;11:e0167096.
    PubMed     Abstract available

  353. YAMAGUCHI S, Hirata K, Toyonaga T, Kobayashi K, et al
    Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
    PLoS One. 2016;11:e0167917.
    PubMed     Abstract available

  354. ZHANG I, Alizadeh D, Liang J, Zhang L, et al
    Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages.
    PLoS One. 2016;11:e0165118.
    PubMed     Abstract available

  355. GILDER AS, Wang L, Natali L, Karimi-Mostowfi N, et al
    Pertussis Toxin Is a Robust and Selective Inhibitor of High Grade Glioma Cell Migration and Invasion.
    PLoS One. 2016;11:e0168418.
    PubMed     Abstract available

  356. SHIMIZU M, Tanaka M, Atomi Y
    Small Heat Shock Protein alphaB-Crystallin Controls Shape and Adhesion of Glioma and Myoblast Cells in the Absence of Stress.
    PLoS One. 2016;11:e0168136.
    PubMed     Abstract available

  357. KROGH PETERSEN J, Jensen P, Dahl Sorensen M, Winther Kristensen B, et al
    Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
    PLoS One. 2016;11:e0169129.
    PubMed     Abstract available

  358. STEIDL E, Pilatus U, Hattingen E, Steinbach JP, et al
    Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.
    PLoS One. 2016;11:e0168113.
    PubMed     Abstract available

  359. HUHNDORF M, Moussavi A, Kramann N, Will O, et al
    Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma Model.
    PLoS One. 2016;11:e0168174.
    PubMed     Abstract available

  360. LI Y, Hou M, Lu G, Ciccone N, et al
    The Prognosis of Anti-Angiogenesis Treatments Combined with Standard Therapy for Newly Diagnosed Glioblastoma: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0168264.
    PubMed     Abstract available

  361. WEN G, Tang C, Zhong C, Li X, et al
    Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0153397.
    PubMed     Abstract available

  362. LIU S, Wang Y, Fan X, Ma J, et al
    Anatomical Involvement of the Subventricular Zone Predicts Poor Survival Outcome in Low-Grade Astrocytomas.
    PLoS One. 2016;11:e0154539.
    PubMed     Abstract available

  363. SCHOB S, Meyer J, Gawlitza M, Frydrychowicz C, et al
    Diffusion-Weighted MRI Reflects Proliferative Activity in Primary CNS Lymphoma.
    PLoS One. 2016;11:e0161386.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.